News

Genoskin awarded grant from Occitania The Occitania Region announced today that it awarded its coveted international development grant to Genoskin. The “Pass Export” grant is awarded to companies that demonstrate significant growth potential abroad. Pass-Export enables companies to pursue their development in new territories. “Genoskin is honored and grateful to be awarded this grant. As we continue to grow, we

Read more

 [ESDR2019] Genoskin partners with Sanofi to present Hypo-InflammaSkin® Genoskin’s team of skin experts will be presenting its latest work at the 49th ESDR Annual Meeting from September 18 to September 21 in Bordeaux, France. To discover our latest research and innovations, meet our Project Manager and Team leader Claire Jardet, Ph.D.  on Thursday 19th at 7 pm and Friday 20th atRead more

Genoskin to exhibit at the 49th Annual Meeting of the European Society for Dermatological Research (ESDR 2019) The 44th Annual Meeting of the European Society for Dermatological Research (ESDR 2019) strives to provide a world-leading platform for the presentation and discussion of state-of-the-art science as it relates to skin biology and investigative dermatology. From September 18th to September 21st, meet our Chief Commercial Officer, EricRead more

Illinois becomes the third state to ban cosmetics tests on animals Last week, Illinois became the third state to ban the sale and manufacture of cosmetic products tested on animals. About a year ago, California was the first state to take a stand against animal testing in cosmetics, Nevada followed a few months later. The law, sponsored by Sen. LindaRead more

InflammaSkin® application presented by Incospharm at the Gordon Research Conference (GRC) on Barrier Function of Mammalian Skin Incospharm is presenting a poster showing one application of our live human psoriasis model, InflammaSkin® at the GRC held in New Hampshire from August 11th to August 16th. InflammaSkin®, testing of innovative anti-inflammatory drugs Poster title: "ICP-5249 reduces dermal inflammatory signaling through autophagy activation" IncospharmRead more

Genoskin will attend the BIO International Convention in Philadelphia, PA The BIO International Convention is a global event regrouping biotech and pharma leaders over intensive networking. The convention is a great opportunity to discuss a wide spectrum of life science and application areas including drug discovery, bio manufacturing, genomics, biofuels, nanotechnology or cell therapy. This year more than 16,000 attendeesRead more